Preview

Millennium final report

Best Essays
Open Document
Open Document
4072 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Millennium final report
Organization and Strategy at Millennium:
Written Report

TABLE OF CONTENTS

Introduction 4
Synopsis 4
Central Problem 5
Issues Identified 6
I. Resistance to Change 6
II. Organizational Structure 8
III. Motivation 9
Recommendations 11
I. General Recommendation 11
II. Motivating Through Change 13
III. Structure 15
IV. Motivation 17
Conclusion 17
Bibliography 19

Introduction
Millennium Pharmaceutical is currently developing new organizational strategies in response to the evolving changes within the biopharmaceutical industry. In our quest to provide organizational recommendations in assisting Millennium in its implementation of new strategies, we have constructed a brief overview of the company and a synopsis of the case, the central problem Millennium is confronted with, an analysis of what has transpired accompanied with applied course concepts pertinent to those of motivation, resistance to change and organizational structure, and a set of recommendations prepared for Millennium to better its ongoing transition and transformation.

Synopsis
Founded in Cambridge, Massachusetts by Mark Levin in 1993, Millennium Pharmaceuticals has since undergone three major phases. Levin’s vision for Millennium was one that amalgamated areas of genetics, biology, chemistry, robotics and computer systems, which pushed him to develop a competitive advantage in research discovery. As information, technology and tools became more prevalent, however, this competitive advantage eroded away, prompting Millennium to pursue acquisitions, initiating its shift in focus away from research discovery and onto drug development and commercialization, placing it in in its second phase. The third and current phase of the company is characterized by the horizontal breadth being narrowed down to three therapeutic classes. As Millennium was shifting further and further away from its initial organizational



Bibliography: Bataille, C. (2014, January 22nd ). Session 6: Theories of work motivation [PowerPoint      slides]. Retrieved from MyCourses. Johns G., & Saks A.L. Organizational Behaviour. 2014. Understanding and Managing Life at Work. Pearson. Chapter 16. ISBN : 9780132161121 Kotter, J. R. (2007). Leading change-why transformation efforts fail. Harvard Business Review, 85(1) Michael, L. (1989). Liar’s poker: Hodder and Stoughton Ltd, London. Chapter 8. Morgan, G. 2006. Images of Organization. SAGE Publications, Thousand Oaks. (pages 11 to 54) O’Reilly, C.A., & Chatman, J. A. (1996). Culture as social control: Corporations, cults, and commitment. Research in organizational behavior, 18, 157-178. Robbins & Judge (2014). Chapter 7 Waggoner & Wulf. (2010). Organization and strategy at Millennium (A). Harvard ID: 9-710-415. Boston, MA: Harvard Business School Publishing

You May Also Find These Documents Helpful

  • Best Essays

    Hrm 587 Final Project

    • 6455 Words
    • 26 Pages

    Ford, J., Ford, L., &D’Amelio, A. (2008). Resistance to change: The rest of the story. Academy of Management Review, 33(2), 362-377.…

    • 6455 Words
    • 26 Pages
    Best Essays
  • Better Essays

    Myers, David G. "Motivation and Work." Psychology. 8th ed. New York: Worty, 2006. 473-80. Print.…

    • 1340 Words
    • 6 Pages
    Better Essays
  • Best Essays

    Neil Patterson

    • 3150 Words
    • 13 Pages

    Robbins, S. P. & Judge, T. A. (2009). Contemporary theories of motivations. In Organizational behavior (13th ed.). (pp. 195-203). Upper Saddle River, NJ: Prentice-Hall.…

    • 3150 Words
    • 13 Pages
    Best Essays
  • Best Essays

    The pharmaceutical company is made up of a number of different functions and departments. Each of these functions is given a responsibility in one area of the company’s activity. These departments are closely related and the success of the company is based on the ability of these functions to work together. The pharmaceutical companies rely on research and development to find new and innovation new drugs. In order for a drug to enter the market it must undergo a series of tests and clinical trials. There are phases the drug must go through and complete in order to meet the requirements of the FDA. The development of a drug is an ongoing journey, and it can take up to 12 years to develop a drug (Pharmaceutical Patents 2006). The pharmaceutical company uses…

    • 4398 Words
    • 18 Pages
    Best Essays
  • Best Essays

    Communicating the Change

    • 1451 Words
    • 6 Pages

    4. Kotter J. Leading Change: Why Transformation Efforts Fail. (Cover story). Harvard Business Review [serial online]. March 1995; 73(2):59-67. Available from: Business Source Complete, Ipswich, MA. Accessed January 20, 2013.…

    • 1451 Words
    • 6 Pages
    Best Essays
  • Powerful Essays

    inside out

    • 10437 Words
    • 47 Pages

    [CU3859] as taught by Mrs. du Pon at HZ University of Applied Sciences. Distinctive use…

    • 10437 Words
    • 47 Pages
    Powerful Essays
  • Powerful Essays

    References: Herzberg, F., Mausner, B., & Snyderman, B. B. (1959). The Motivation to Work (2nd ed.). New York: John Wiley & Sons.…

    • 1145 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    Yamada reorganization of drug discovery at GlaxoSmithKline (GSK) following a merger to combat bureaucracy in decision making, approval, and authorization. This reorganization was necessary for the continued success of the company. Often the process for drug discovery and market is a slow and tedious process which can cost a company a lot in resources and financially. The smaller biotech companies are able to move quicker and push new drugs to market faster. The shift, Yamada thinks, will help produce an entrepreneurial environment akin to a smaller, biotechnology outfit. This reorganization placed nearly 2,000 research scientists into six centers of excellence in drug discovery (CEDD). Each CEDD focused on a small set of therapeutic areas and possessed decision rights over the progression of pharmaceutical compounds through the early stages of development. These groups managed the pipeline from Lead Optimization through Proof of Concept. Each CEDD had full control over its own budget which could be spent internally or externally to deliver their best possible pipeline. The goals in each of these moves was to drive accountability deeper into the organization, reduce central oversight as much as necessary and foster a “biotech-like” atmosphere in a very large bio/pharmaceutical company.…

    • 756 Words
    • 4 Pages
    Good Essays
  • Better Essays

    being indie

    • 942 Words
    • 3 Pages

    1. Using the strategic planning process discussed in this chapter, what was the core problem to be solved by Millennium? What were all their potential alternative solutions to that problem?…

    • 942 Words
    • 3 Pages
    Better Essays
  • Good Essays

    Analysis on Merck

    • 1280 Words
    • 6 Pages

    Merck is one of the biggest pharmaceutical companies in the world today. Although encountered with success, it still faces many problems today while trying to be the market leader competing against its competition. While being research and development driven company, Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. The main issue that seems to come up is that how far it can progress with the dual challenge of hitting peak annual financial performance while keeping the research pipeline full continued to weigh on senior management. Through the late 80s to early 90s, Merck was able to boast profits and sales through biochemistry drugs that were seen as breakthrough drugs in this new market. With this sudden boom competitors started to take notice and emulate Merck’s business model. This success also brought up a number of questions within Merck as a company; mainly how was Merck going to keep up with its numbers and keep pumping new drugs into the market.…

    • 1280 Words
    • 6 Pages
    Good Essays
  • Powerful Essays

    Workplace Ethnography

    • 1790 Words
    • 6 Pages

    Herzberg, F., Mausner, B., & Snyderman, B. (1993). The motivation to work (1st ed.). New Brunswick, N.J., U.S.A.: Transaction Publishers.…

    • 1790 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    Pharmaceutical Marketing

    • 7563 Words
    • 31 Pages

    Need of New Pharmaceutical Marketing Strategies (2010, March, 23). Pharmaceutical & Drug Manufacturer Resources. Retrieved from: http://www.pharmaceutical-drug-manufacturers.com/articles/marketing-strategy.html…

    • 7563 Words
    • 31 Pages
    Powerful Essays
  • Powerful Essays

    HERZBERG, F . , MAUSNER, B. & SNYDERMAN, B . (1959). The Motivation to Work, 2nd ed. New York:…

    • 3806 Words
    • 16 Pages
    Powerful Essays
  • Powerful Essays

    Bpr Case Study

    • 6411 Words
    • 26 Pages

    chang e for the purpos e of uncovering ho w they achieved success. The organization we examined…

    • 6411 Words
    • 26 Pages
    Powerful Essays
  • Good Essays

    akala

    • 780 Words
    • 5 Pages

    The strategy is to continue to grow as a research-based biopharmaceuticalcompany focused on offering quality products to customers and potentialpartners. Key aspects of the strategy are to:…

    • 780 Words
    • 5 Pages
    Good Essays